SARS_CoV 2 Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) - 2022
Completed
  • SARS-CoV 2
  • Los Angeles, California
  • +10 more
2022-03-17
Mar 17, 2022
B
Anti-SARS Cov-2 T Cell Infusions for COVID 19 - 2021
Terminated
  • SARS-CoV 2
  • +2 more
  • Dose Finding Phase (MTD)
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
2022-01-04
Jan 4, 2022
J
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Active, not recruiting
  • SARS-CoV 2
  • SARS-CoV-2 convalescent plasma
  • Plasma from a volunteer donor
  • Birmingham, Alabama
  • +24 more
2021-11-15
Nov 15, 2021